Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial-Mesenchymal Transition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04323917
What this trial is testing

Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 850
Not applicableStudy completedNCT06055660
What this trial is testing

Moesin Expression in Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 50
Not applicableStudy completedNCT03458819
What this trial is testing

EMT in Peritoneal Dialysis Patients

Who this might be right for
Peritoneal Dialysis Complication
University of Colorado, Denver 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04077099
What this trial is testing

REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Regeneron Pharmaceuticals 95
Early research (Phase 1)Study completedNCT02412462
What this trial is testing

Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy

Who this might be right for
Solid TumorMetastatic Cancer
Alethia Biotherapeutics 15
Testing effectiveness (Phase 2)Looking for participantsNCT06669117
What this trial is testing

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

Who this might be right for
Solid TumorMET Alteration
Pierre Fabre Medicament 140
Not applicableStudy completedNCT03732872
What this trial is testing

Epithelial Mesenchymal Transition Markers in OSMF

Who this might be right for
Oral Submucous Fibrosis
The Oxford Dental College, Hospital and Research Center, Bangalore, India 185
Testing effectiveness (Phase 2)Looking for participantsNCT05541822
What this trial is testing

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

Who this might be right for
Advanced Solid Tumors
Abion Inc 178
Not applicableUnknownNCT02940977
What this trial is testing

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Who this might be right for
Prostatic NeoplasmsProstatic Adenoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 120
Early research (Phase 1)Study completedNCT03021642
What this trial is testing

Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers

Who this might be right for
Healthy
Merck KGaA, Darmstadt, Germany 24
Early research (Phase 1)Study completedNCT02221882
What this trial is testing

LY3164530 in Participants With Cancer

Who this might be right for
NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 29
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Not applicableStudy completedNCT02579460
What this trial is testing

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

Who this might be right for
Barrett's EsophagusGastroesophageal Reflux Disease
Dallas VA Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Testing effectiveness (Phase 2)UnknownNCT05176665
What this trial is testing

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

Who this might be right for
NeoplasmsNeoplasm MetastasisMetastatic Gastrointestinal Carcinoid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd. 152
Early research (Phase 1)Looking for participantsNCT07181681
What this trial is testing

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumor
BeOne Medicines 63
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Early research (Phase 1)Active Not RecruitingNCT02609776
What this trial is testing

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Janssen Research & Development, LLC 751
Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Next Page